相似化合物
1188328-22-4 32886-55-8 843666-26-2上下游产品
N-(1-氧代十六烷基)-L-谷氨酸叔丁酯 (S)-5-(Tert-Butoxy)-5-Oxo-4-Palmitamidopentanoic Acid 536721-25-2
棕榈酸 N-羟基琥珀酰亚胺酯 Palmitic Acid N-Succinimide Ester 14464-31-4棕榈酸 N-羟基琥珀酰亚胺酯置于碳酸氢钠,三乙胺体系中,用 四氢呋喃,水,二甲基亚砜 用作溶剂,化学反应 2.0H,反应生成(2S)-5-[(2,5-二氧代-1-吡咯烷基)氧基]-5-氧代-2-[(1-氧代十六烷基)氨基]戊酸叔丁酯
参考文献: Insulin Dimer-Incretin Conjugates[fr] Conjugués Dimères D'Insuline-Incrétine
标题: Insulin Dimer-Incretin Conjugates[fr] Conjugués Dimères D'Insuline-Incrétine
摘要:已披露将胰岛素二聚体与至少具有一种胰岛素增效活性的肽共轭化.
海关参考信息
- 2905122000-异丙醇
2905143000-叔丁醇
2909110000-乙醚
2912110000-甲醛 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-2019177392-A1
优先权日:2014-09-23
标 题 :Synthesis of glp-1 peptides
发明人:PENIAS NAVON SHARON; NAVEH SHIRLY; VASILEIOU ZOI; BARLOS KONSTANTINOS
权利人:NOVETIDE LTD
摘要:Disclosed are processes for the synthesis of GLP-1 peptides, such as liraglutide and semaglutide, and a process for purifying liraglutide.
专利号:WO-2025078040-A1
优先权日:2023-10-09
标 题 :Lysine salt and method of manufacturing a lysine derivative
发明人:HINTERMANN TOBIAS; SCHWINDLING JOACHIM; RÜEFLI PASCAL; SCHÖNLEBER RALPH O; WILLIG FELIX; MELZIG LAURIN; ERMERT PHILIPP; KÜMIN MICHAEL; SCHWIZER NATASCHA; SCHNEIDER ANGELIKA; SCHMID LUCIUS
权利人:BACHEM HOLDING AG
摘要:The invention relates to a Bsmoc-protected lysine salt of formula (1 X ), e.g., a hydrochloric acid salt (n = 1, HY = hydrochloric acid). It further relates to a method of manufacturing Bsmoc-protected lysine derivatives, which employs the Bsmoc-protected lysine salt of formula (1 X ) and comprises the step of reacting the epsilon amino group of lysine with an 10 activated carboxylic acid derivative. Some of the obtainable Bsmoc-protected lysine derivatives with their side chain modification are useful as starting materials in solid phase peptide synthesis.
专利号:EP-3819308-A1
优先权日:2019-11-07
标 题:Process for the manufacture of derivatized amino acids
发明人:RICCI ANTONIO; CALLENS ROLAND; NUIJENS TIMO; CABRI WALTER
权利人:FRESENIUS KABI IPSUM S R L
摘要:The present invention relates to peptide synthesis, and in particular to a process for the manufacture of protected amino acids substituted at their side-chains. In addition, the present invention relates to the use of such protected amino acids in the preparation of GLP-1 analogues, such as for instance liraglutide and semaglutide.
专利号:US-2018057558-A1
优先权日:2014-09-23
标题 :Synthesis of GLP-1 Peptides
专利号:CN-113150108-A
优先权日:2021-05-21
标 题 :A kind of solid-phase synthesis method of liraglutide
专利号:CN-113150108-B
优先权日:2021-05-21
标 题:A kind of solid-phase synthesis method of liraglutide